F.D.A. Approves New Treatment for Early Alzheimer’s

F.D.A. Approves New Treatment for Early Alzheimer’s

The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
Expect Higher Health Insurance Premiums, but Not a Lot Higher

Expect Higher Health Insurance Premiums, but Not a Lot Higher

Benefit costs may go up as much as 6 percent. Wary of driving workers away, many employers may not pass on the full increases, analysts say.